There is no single test that confirms ALS. Diagnosis relies on a combination of neurological exams, electrical nerve testing, blood work, imaging, and ruling out other conditions that look similar. The process typically takes 10 to 16 months from the first symptom to a confirmed diagnosis, though some people wait more than two years.
That long timeline isn’t due to a lack of urgency. ALS shares symptoms with dozens of other conditions, and doctors need to systematically eliminate each one before arriving at a diagnosis. Here’s what that process actually involves.
The Neurological Exam Comes First
A neurologist will start with a detailed physical exam, looking for a specific pattern: signs of damage to both upper motor neurons (the nerve cells in your brain that send movement signals) and lower motor neurons (the nerve cells in your spinal cord that carry those signals to your muscles). ALS attacks both, and finding evidence of both types of damage in the same person is a hallmark of the disease.
Upper motor neuron signs include abnormally brisk reflexes (the doctor taps your knee and the response is exaggerated), stiffness in the limbs, and slowness of movement. Lower motor neuron signs include visible muscle twitching (fasciculations), muscle wasting, and weakness. Fasciculations often show up early, particularly in the tongue and limbs. As the disease progresses, muscle wasting becomes more obvious and may affect hand dexterity, gait, or speech.
The neurologist will also ask detailed questions about your symptom timeline. ALS progresses gradually over weeks and months. If weakness came on suddenly, over hours or days, the diagnosis is almost certainly something else.
Electrical Nerve Testing (EMG)
Electromyography, or EMG, is the most important diagnostic test for ALS. It measures the electrical activity in your muscles and the speed at which your nerves conduct signals. During the test, a thin needle electrode is inserted into several muscles across different body regions, including your arms, legs, and sometimes the tongue or back muscles.
What doctors are looking for is a pattern showing that motor neurons are dying and the remaining ones are trying to compensate. Healthy muscles are electrically quiet at rest, but in ALS, muscles may show spontaneous electrical activity even when you’re not trying to move them. The test can also reveal that surviving nerve cells have sprouted new branches to take over for dead ones, a sign of ongoing nerve loss.
EMG is particularly valuable because it can detect motor neuron damage in body regions where you haven’t noticed symptoms yet. Finding widespread nerve involvement across multiple regions strengthens the case for ALS rather than a localized problem like a pinched nerve.
Blood Tests, Imaging, and Spinal Taps
Blood work and imaging don’t confirm ALS directly. Instead, they help rule out the long list of conditions that can mimic it. Your doctor will likely order MRI scans of the brain and spine to look for structural problems like compressed nerves, tumors, or spinal cord abnormalities. Blood tests screen for infections, inflammatory conditions, thyroid disorders, and other metabolic problems that could explain your symptoms.
In some cases, a lumbar puncture (spinal tap) may be performed to analyze cerebrospinal fluid. One emerging tool is measuring levels of a protein called neurofilament light chain, which nerve cells release when they’re damaged. In studies, this protein in spinal fluid distinguished ALS patients from healthy individuals with 97% sensitivity and 95% specificity. Blood-based versions of the same test are slightly less precise but still useful, catching about 89 to 90% of cases. While not yet a standalone diagnostic test everywhere, neurofilament levels are increasingly used to support the clinical picture.
Ruling Out ALS Mimics
A significant part of the diagnostic process is eliminating other explanations. The list of conditions that can look like ALS is long and depends on which symptoms you’re experiencing.
- If weakness is mainly in the limbs with stiffness: Cervical myelopathy (spinal cord compression in the neck), spinal cord tumors, hereditary spastic paraparesis, or multiple sclerosis-related spinal cord inflammation.
- If weakness is mainly in the limbs with muscle wasting: Pinched nerves, chronic inflammatory nerve disease (CIDP), multifocal motor neuropathy, or muscle diseases like inclusion body myositis.
- If symptoms started in the face, throat, or tongue: Brainstem lesions, cranial nerve problems, or myasthenia gravis.
- If onset was rapid: Guillain-Barré syndrome, West Nile virus, or myasthenia gravis are more likely suspects.
Some of these conditions are treatable, which is one reason doctors are thorough before settling on an ALS diagnosis. Multifocal motor neuropathy, for instance, can closely resemble ALS but responds well to treatment. Getting the diagnosis right matters enormously.
Genetic Testing
Current guidelines recommend that all people diagnosed with ALS undergo genetic testing for mutations in four key genes: C9orf72, SOD1, FUS, and TARDBP. These are the most commonly implicated genes in hereditary ALS.
About 5 to 10% of ALS cases are familial, meaning they run in families. Among those with a family history, genetic testing identifies a known mutation in 60 to 70% of cases. Even for people without a family history, genetic testing has become standard because some mutations occur spontaneously, and identifying a specific mutation can influence treatment options. A targeted therapy now exists for one genetic form of ALS, making this testing more practically relevant than it was just a few years ago.
How the Diagnosis Is Made
The current standard is the Gold Coast criteria, which simplified the diagnostic process considerably. Under older systems (called El Escorial and Awaji criteria), patients were classified into categories like “suspected,” “possible,” “probable,” and “definite” ALS based on how many body regions showed both upper and lower motor neuron signs. Those categories caused real problems: patients labeled “possible” ALS were sometimes excluded from clinical trials and experienced significant distress from the ambiguous label, even though their disease progressed at the same rate as “definite” cases.
The Gold Coast criteria eliminated those tiers. Now, the answer is simply ALS or not ALS. To qualify, a person needs progressive motor impairment documented by history or clinical exam, plus evidence of upper and lower motor neuron dysfunction in at least one body region (or lower motor neuron dysfunction in at least two regions), with no better explanation for the symptoms.
Why Diagnosis Takes So Long
The average diagnostic delay of 10 to 16 months frustrates patients and families, but several factors drive it. Early symptoms are often vague: a foot that drags slightly, a hand that fumbles with buttons, or a voice that sounds a little different. These are common complaints that can point to dozens of conditions. Many people see their primary care doctor first, then get referred to an orthopedist or physical therapist before eventually reaching a neurologist.
An analysis of 21 retrospective studies found the median time from first symptom to diagnosis ranged from 9 to 27 months. The wide range reflects differences in symptom onset location, access to specialists, and how quickly other diagnoses are ruled out. Patients whose symptoms start in the limbs tend to take longer to diagnose than those with early speech or swallowing problems, partly because limb weakness has a much broader list of alternative explanations.
Seeking care at a multidisciplinary ALS clinic can streamline the process. These centers bring together neurologists, physiatrists, pulmonologists, speech therapists, dietitians, and other specialists in one visit, reducing the back-and-forth between appointments that stretches timelines at general neurology practices.